CollPlant Biotechnologies Commences ~$2.6M Offering Of Ordinary Share, Warrants
CollPlant Biotechnologies (NASDAQ: CLGN ), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today announced that it has entered into a definitive agreement for the issuance and sale